1The Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Southport, QLD, 4215, Australia
2Division of Plant Pathology, ICAR-Indian Agricultural Research Institute, New Delhi, 110012, India
3School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Southport, 4215, Queensland, Australia
4Global Virus Network (GVN) Centre for Excellence in Arboviruses, Australia
*Corresponding Author shambhavi.rao@griffithuni.edu.au
Online Published on 10 January, 2024.
JN.1 is a new emerged sub variant of Covid-19. It was noticed emerged first in Luxemberg and USA in late 2023 and has been spread to China, India, Singapore and France by December 2023. JN.1 has high resistance across receptor binding domain classes 1, 2, and 3 and shows high immune evasion as compared to resistant strains and BA.2.86. According to the World Health Organization, the JN.1 is a variant of interest. At present, the sub variant cases are arising in many countries. The importance of this emerged sub variant is discussed.
Corona virus new variant, Epidemiology, Management
